Abbott Laboratories Common Stock · Transaction Sep 18, 2026 · Filed Oct 12, 2026 · $1,001 to $15,000
NEW YORK STOCK EXCHANGE, INC. · ABT
+0.20% · +$0.2100 · Vol Not reported
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Abbott Laboratories
Health Care
$104.89
Follow $ABT
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ABT by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredFri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET · ABT
MethodologyABT
Abbott Laboratories
Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
69/ 100
Veridion Score
Upper range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
AI Analysis
SovereignWhy is ABT moving today?
Sovereign unlock connects news, insider activity, analyst moves, and available price action.
About Abbott Laboratories
PHARMACEUTICAL PREPARATIONSListed since
1949
Employees
115K
Country
US
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$105.65
Day high
$105.88
Day low
$104.19
Previous close
$104.68
52W high
$130.59
-19.68% from high
52W low
$82.56
46% of range
Market cap
$181.5B
P/E
33.46×
EPS
$3.11
Beta
-0.39
Shares out
1.7B
Avg volume
9.2M
VWAP
$104.68
Last session
Price history computed in-house
1W
+5.31%
1M
+2.22%
3M
+3.18%
1Y
-18.40%
YTD
-16.28%
SMA 50 $105.87 · below
SMA 200 $102.81 · above
52W position 46%
ABT overview
Veridion Score
69
Registered · 2026-10-16
6 of 6 factors measured
Latest receipt rows
5
Gilbert Ray Cisneros, Jr. · Purchase
13F holders
1
Two Sigma Investments, LP
Receipt-backed holder profiles
SEC industry peers
ABT peers
Related filings and maps
Public disclosures
Congress activity in ABT
49 filers · 80 buys · 66 sells (3 labeled S (partial)) · 1 other · Dec 30, 2013 to Sep 18, 2026 · House 129 / Senate 18
All available history · Latest 5 of 147 lines · Read Oct 18, 2026, 9:13 AM UTC
Official filing ↗
Abbott Laboratories Common Stock · Transaction Jul 30, 2026 · Filed Aug 14, 2026 · $1,001 to $15,000
Abbott Laboratories Common Stock · Transaction Jul 14, 2026 · Filed Aug 18, 2026 · $15,001 to $50,000
Rick LarsenSell
Abbott Laboratories Common Stock · Transaction Jul 8, 2026 · Filed Jul 12, 2026 · $1,001 to $15,000
Abbott Laboratories Common Stock · Transaction Jun 16, 2026 · Filed Jul 2, 2026 · $1,001 to $15,000
Federal contracts
ABT contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ABT in this window.
Lobbying spend
ABT lobbying filings, year to date.
Registered lobbying filings matched to Abbott Laboratories.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ABT in this window.
Analyst ratings
Sovereign unlock shows available analyst consensus for ABT.